| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ACE inhibitors in patients with vascular disease: Should the peace trial change medical practice?
|
Carey, Robert M.
|
|
2005
|
7 |
2 |
p. 119-120
|
article
|
| 2 |
Advanced-glycation end products in insulin-resistant states
|
Soldatos, Georgia
|
|
2005
|
7 |
2 |
p. 96-102
|
article
|
| 3 |
BENEDICT in the treatment of hypertension
|
Logan, Alexander
|
|
2005
|
7 |
2 |
p. 121-123
|
article
|
| 4 |
Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species
|
Whiteside, Catharine I.
|
|
2005
|
7 |
2 |
p. 148-154
|
article
|
| 5 |
Is angiotensin II made inside or outside of the cell?
|
Chai, Wenxia
|
|
2005
|
7 |
2 |
p. 124-127
|
article
|
| 6 |
Metabolic syndrome and endothelial dysfunction
|
Fornoni, Alessia
|
|
2005
|
7 |
2 |
p. 88-95
|
article
|
| 7 |
Metabolic syndrome therapy: Prevention of vascular injury by antidiabetic agents
|
Dominguez, Ligia J.
|
|
2005
|
7 |
2 |
p. 110-116
|
article
|
| 8 |
Molecular evidence of tissue renin-angiotensin systems: A focus on the brain
|
Sakai, Koji
|
|
2005
|
7 |
2 |
p. 135-140
|
article
|
| 9 |
Molecular evidence of tissue renin-angiotensin systems: A focus on the brain
|
Sakai, Koji
|
|
|
7 |
2 |
p. 135-140
|
article
|
| 10 |
Pathophysiology and clinical meaning of small resistance artery remodeling
|
Rosei, Enrico Agabiti
|
|
2005
|
7 |
2 |
p. 79-80
|
article
|
| 11 |
Role of angiotensin III in hypertension
|
Reaux-Le Goazigo, Annabelle
|
|
2005
|
7 |
2 |
p. 128-134
|
article
|
| 12 |
The metabolic effects of angiotensin-receptor blockers
|
Tuck, Michael L.
|
|
2005
|
7 |
2 |
p. 85-87
|
article
|
| 13 |
The metabolic syndrome in the Asian population
|
Rakugi, Hiromi
|
|
2005
|
7 |
2 |
p. 103-109
|
article
|
| 14 |
The salt paradox and its possible implications in managing hypertensive diabetic patients
|
Vallon, Volker
|
|
2005
|
7 |
2 |
p. 141-147
|
article
|
| 15 |
Web alert
|
|
|
2005
|
7 |
2 |
p. 81-82
|
article
|
Journal description